This inference seems reasonable in light of our recent report showing the negative regulation of BTLA expression in B cells of CLL patients through epigenetic modulation by miR-155-5p, resulting in a lower BTLA level on CLL B cells. This evidence concerns the gene BTLA and B-cell chronic lymphocytic leukemia.